Search Results - "Cardona, Jose Vicente"

Correlation of safety and efficacy of atezolizumab therapy across indications by Durán-Pacheco, Gonzalo, Chandler, G Scott, Maiya, Vidya, Socinski, Mark A, Sonpavde, Guru, Puente, Javier, Essioux, Laurent, Carter, Corey, Cardona, Jose Vicente, Mohindra, Rajat, Naidoo, Jarushka

“…The association between safety and efficacy of immune checkpoint inhibitors is known, but the correlation between severity and impact of specific organ…”
Get full text

Baseline autoantibody profiling in patients with NSCLC with pre-existing autoimmune diseases or who had received prior anti-PD-1 therapy before enrolling in the TAIL study by Rodriguez-Abreu, Delvys, Budde, Petra Ilse, Zucht, Hans-Dieter, Shrivastava, Divya, Kilian, Annika Loredana, Höglander, Elen, Shoshkova, Stefaniya, Markovic, Marija, Kaul, Monika Dulloo, Cardona, Jose Vicente, Chandler, G Scott, Mohindra, Rajat

“…2512 Background: Patients (pts) with pre-existing autoimmune diseases (AID) and prior immune checkpoint inhibitor (ICI) experience were historically excluded…”
Get full text

Bevacizumab (B), cisplatin (C), and pemetrexed (P) plus maintenance B in chemonaive patients (pts) with advanced nonsquamous non-small cell lung cancer (nsNSCLC): A phase II study by Lopez-Vivanco, Guillermo, Carrera, Sergio, Sancho, Aintzane, Marrodan, Ines, Azcona, Eider, Iruarrizaga, Eluska, Rubio, Itziar, Muñoz, Alberto, Cardona, Jose Vicente

“…Abstract only e18031 Background: B in combination with platinum doublets followed by continuation maintenance with B prolongs survival and delays progression…”
Get full text

Long-term survivors with advanced nonsquamous non-small cell lung cancer (nsNSCLC) treated with first-line (1L) chemotherapy (CT) plus bevacizumab (B) and maintenance (mtc) B by de Castro, Javier, Isla, Dolores, Gonzalez Larriba, Jose Luis, Vazquez Estevez, Sergio, Massuti, Bartomeu, Sanchez Torres, Jose Miguel, Domine, Manuel, Calles, Antonio, Cardona, Jose Vicente, Garrido López, Pilar

“…Abstract only e18055 Background: B plus CT followed by mtc B has been shown to improve outcomes in patients (pts) with nsNSCLC. In the clinical setting, some…”
Get full text